ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,276, issued on Sept. 29, was assigned to VectivBio AG (Basel, Switzerland).

"Manufacture, formulation and dosing of apraglutide" was invented by Federico Bolognani (Biel-Benken, Switzerland), Gleb Feldman (Oxford, Great Britain), Jean-Marie Receveur (Copenhagen, Denmark) and Torsten Weiss (Ishoej, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods of making, formulating and administering GLP-2 analogs."

The patent was filed on Jan. 28, 2025, under Application No. 19/039,081.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO...